Bevacizumab for the treatment of non-small-cell lung cancer (terminated appraisal)

  • Technology appraisal
  • TA148
  • Published: 

History

Lung cancer (non-small cell) - Bevacizumab: final scope

Letter to consultees and commentators informing appraisal suspension.